Do Posaconazole Tablets Carry Hypertension, Hypokalemia Risks?
Rebecca Wittenberg, PharmD, spoke to MPR at IDWEEK 2017 about the research paper she co-authored on posaconazole and hypertension, hypokalemia risks.
IDWEEK 2017
Are Statins Appropriately Utilized Among HIV Patients?
MPR spoke with Gerome Escota, MD, at IDWeek 2017, who co-authored a review at a large urban outpatient center to identify the proportion of appropriate statin use.
Does Abacavir Up the Risk for MI and CAD?
MPR caught up with Mark Shaefer, PharmD, at IDWEEK 2017 to speak about the research he led concerning abacavir use and myocardial infarction (MI) risks.
Safety of Single Dose IV Peramivir Examined in Pediatric Influenza
Age-appropriate doses of IV peramivir were compared to five days of oral oseltamivir in patients aged 0-17 years.
High Completion Rate for Isoniazid-Rifapentine in Latent TB
Effective treatment of latent tuberculosis infection is key to TB control efforts and approaching the goal of TB elimination, the authors reported.
High Cure Rates, Microbiologic Eradication With IV Fosfomycin
Study patients were randomized to 1-hour IV fosfomycin 6g infusion every 8 hours (18 g total daily dose) or IV piperacillin/tazobactam 4.5g infused over 1 hour every 8 hours for a fixed 7 days.
Safety Profiles Similar for Delafloxacin, Vancomycin/Aztreonam for ABSSSI
Researchers compared the integrated safety outcomes between delafloxacin and vancomycin/aztreonam from two Phase 3 ABSSSI studies.
For Latent TB, 3-Month Rifapentine + Isoniazid May Be Favorable for Some
Clinical and demographic profiles of patients were compared on those who completed the 9H vs. 3HP regimens with a focus on adverse events, which can commonly cause treatment discontinuation.
No Statistical Difference for Doxycycline, Azithromycin in CAP Outcomes
The ceftriaxone + doxycycline regimen has been favored in light of ‘recent concerns of increased cardiovascular risk associated with azithromycin
ART Limits Appropriate Contraceptive Options for Women with HIV
The researchers sought to determine the type and frequency of hormonal contraceptives and ART prescribed to women with HIV infection and prevalence of resulting drug to drug interaction potential.
